» Articles » PMID: 35834093

Risk Factors Associated with Augmented Renal Clearance in a Mixed Intensive Care Unit Population: a Retrospective Study

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2022 Jul 14
PMID 35834093
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Augmented renal clearance is increasingly recognized in critically ill patients. This condition may lead to suboptimal dosing of renally excreted medications.

Aim: Our primary objective was to identify demographic and clinical factors associated with augmented renal clearance in a mixed critically ill population.

Method: This retrospective single center observational cohort study evaluated patients admitted in a mixed adult intensive care unit for augmented renal clearance, defined as a creatinine clearance of ≥ 130 ml/min/1.73m through weekly 24-h urine collection. Variables associated with augmented renal clearance were identified using univariate analysis, then served as covariates in a backward stepwise logistic regression. Goodness-of-fit of the model was assessed and receiver operating characteristic curve was generated.

Results: Augmented renal clearance was observed in 25.3% of the study cohort (n = 324). Age below 50 years (adjusted odds ratio 7.32; 95% CI 4.03-13.29, p < 0.001), lower serum creatinine at intensive care admission (adjusted odds ratio 0.97; 95% CI 0.96-0.99, p < 0.001) and trauma admission (adjusted odds ratio 2.26; 95% CI 1.12-4.54, p = 0.022) were identified as independent risk factors. Our model showed acceptable discrimination in predicting augmented renal clearance (Area under receiver operating characteristic curve (0.810; 95% CI 0.756-0.864, p < 0.001)).

Conclusion: We identified age below 50 years, lower serum creatinine upon intensive care admission and trauma as independent risk factors for augmented renal clearance, consistent with the literature suggesting that patients with low serum creatinine upon admission could have a higher risk of developing augmented renal clearance.

Citing Articles

Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.

Xu W, Qu Q, Teng X, Zhuang H, Liu S, Wang Y Eur J Pediatr. 2023; 183(1):51-60.

PMID: 37861791 DOI: 10.1007/s00431-023-05272-x.


External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients.

Huang C, Guiza F, Gijsen M, Spriet I, Dauwe D, Debaveye Y Antibiotics (Basel). 2023; 12(4).

PMID: 37107060 PMC: 10135364. DOI: 10.3390/antibiotics12040698.

References
1.
Bilbao-Meseguer I, Rodriguez-Gascon A, Barrasa H, Isla A, Solinis M . Augmented Renal Clearance in Critically Ill Patients: A Systematic Review. Clin Pharmacokinet. 2018; 57(9):1107-1121. DOI: 10.1007/s40262-018-0636-7. View

2.
Mahmoud S, Shen C . Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing. Pharmaceutics. 2017; 9(3). PMC: 5620577. DOI: 10.3390/pharmaceutics9030036. View

3.
Udy A, Baptista J, Lim N, Joynt G, Jarrett P, Wockner L . Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*. Crit Care Med. 2013; 42(3):520-7. DOI: 10.1097/CCM.0000000000000029. View

4.
Huttner A, von Dach E, Renzoni A, Huttner B, Affaticati M, Pagani L . Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. Int J Antimicrob Agents. 2015; 45(4):385-92. DOI: 10.1016/j.ijantimicag.2014.12.017. View

5.
Baptista J, Roberts J, Sousa E, Freitas R, Deveza N, Pimentel J . Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram. Crit Care. 2014; 18(6):654. PMC: 4277659. DOI: 10.1186/s13054-014-0654-2. View